What's new? Log in Free sign up

Helius Medical (HSDT) News and press releases

Company Profile

News

From Benzinga Pro

Helius Medical Technologies Announced Participation Of Neurology Center Of New England In Its Therapeutic Experience Program

News, Penny Stocks

Helius Medical Technologies, Inc. (Nasdaq: HSDT) today announced the addition of Neurology Center of New England, P.C. ("NCNE") to its Therapeutic Experience Program (TEP).

Helius Medical Technologies Announces Extension Of Patient Therapy Access Program

Helius Medical Technologies (NASDAQ:HSDT) today announced the extension of a program that puts the company's Portable Neuromodulation Stimulator (PoNS®) into the hands of qualified Americans with

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 258 companies hit new 52-week lows.

Looking Into Helius Medical Tech's Return On Capital Employed

Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

Maxim Group Initiates Coverage On Helius Medical Tech with Buy Rating, Announces Price Target of $1

News, Price Target, Initiation, Analyst Ratings

Maxim Group analyst Anthony Vendetti initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Buy rating and announces Price Target of $1.

Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers VEON Ltd. (NASDAQ: VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion).

Watching Helius Medical; Zacks Investment Research Upgrades To Buy

Upgrades, Analyst Ratings

https://www.zacks.com/stock/news/2019568/helius-medical-technologies-inc-hsdt-moves-to-buy-rationale-behind-the-upgrade

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday

News, Penny Stocks, Short Sellers, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share.

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Helius Medical Tech Q3 EPS $(0.12) Beats $(0.21) Estimate, Sales $196.00K Beat $170.00K Estimate

Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.21) by 42.86 percent. This is a 94.03 percent increase over losses of $(2.01) per share

Earnings Scheduled For November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Press releases

From Benzinga Pro

Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022

Markets, Press Releases

-- Q4 2022 revenue projected to range from $275,000 to $285,000 ---- Full year 2022 revenue projected to range from $780,000 to $790,000 ---- Unaudited year end cash balance of $14.5 million -- NEWTOWN, Pa., Jan. 23,

Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program

Health Care, Press Releases

-- Fifth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects' adherence to PoNS® therapy for gait improvement in Multiple

Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis

Health Care, Press Releases, General

NEWTOWN, Pa., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ:HSDT) today announced the extension of a program that puts the company's Portable Neuromodulation Stimulator (PoNS®) into the

Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk

Press Releases, General

NEWTOWN, Pa., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ:HSDT) launched a new e-commerce site that makes it easier for Americans experiencing issues with their gait to obtain the company's

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

News, Financing, Press Releases

NEWTOWN, Pa., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that,

Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results

Earnings, Press Releases

-- Total Q3 revenue up 80% over prior year ---- Cash on hand expected to fund operations through 2023 ---- Company to host call at 8:30am today -- NEWTOWN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical